SLV-154 Treatment of Metastatic Solid Tumors

NCT06771219 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)
NSCLC
SCLC
Cervical Cancer Metastatic
Breast Cancer Metastatic
Endometrial Cancer
Ovarian Cancer
Urothelial Cancer
Sarcoma
Thyroid Cancer

Interventions

DRUG: SLV-154

Sponsor

Solve Therapeutics